Breath Test for Chemicals (Volatile Organic Compounds)

Sponsor
National Cancer Institute (NCI) (NIH)
Overall Status
Completed
CT.gov ID
NCT01437033
Collaborator
(none)
5
1
60.8
0.1

Study Details

Study Description

Brief Summary

Background:
  • Some types of cancer, like cancer of the esophagus, are difficult to detect at an early stage. A possible detection method involves collecting breath samples to look for chemicals that may be signs of cancer. However, more research is needed to determine how different chemicals appear in different breath samples. This study will involve healthy volunteers.
Objectives:
  • To study chemicals appearing in breath samples of healthy volunteers.
Eligibility:
  • Healthy volunteers between 30 and 60 years of age.
Design:
  • Participants will fast overnight (midnight to morning) and then provide two breath samples taken 5 minutes apart.

  • Breath samples will be collected on days 1, 49, and 98 of the study

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Background:

    Although breath tests are common for specific uses where the biomarker is highly concentrated (e .g. alcohol, urea for Helicobacter prylori infection), lower concentration compounds in the breath can also provide information on exogenous exposures and endogenous metabolic processes.

    Employing standardized collection techniques and high sensitivity measurement technologies have shown that breath profiles can accurately identify people with diseases such as breast cancer and lung cancer.

    Breath profiling technologies have great potential as non-invasive tools for diagnosis and risk stratification of precancerous disease as well as elucidation of the causes of cancer.

    Prior to using breath profiles for these purposes it is essential to assess how much of the breath profile and which parts of the breath profile are relatively stable over a period of time.

    Objectives:

    The primary objective of this pilot study is to assess the intra-individual variability of breath profiles sampled over a period of 98 days.

    Eligibility:

    DCEG volunteers aged 30-60 years, inclusive.

    Design:

    Pilot study.

    Five DCEG volunteers will be enrolled for this study.

    We will assess breath profiles sampled in duplicate at three time periods (days 1, 49 and 98).

    We will calculate a coefficients of variation (CV) to determine the proportion and parts of the breath profile which have values less than 10% when collected on the same day,49 days apart, and 98 days apart.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    5 participants
    Observational Model:
    Other
    Time Perspective:
    Prospective
    Official Title:
    A Pilot Study of a Breath Test for Assessment of Volatile Organic Compounds
    Study Start Date :
    Aug 29, 2011
    Study Completion Date :
    Sep 23, 2016

    Outcome Measures

    Primary Outcome Measures

    1. Statistics of robustness (CV, ICCs) [98 days]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    30 Years to 60 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    • INCLUSION CRITERIA:

    DCEG volunteers aged 30-60 years, inclusive.

    EXCLUSION CRITERIA:

    Aged less than 30 years. Aged 61 years or older. Individuals who identify themselves to be in any one of the following categories over the next 4 month period:

    • Plan to initial a large change in their daily amount of physical activity

    • Plan to make large changes to their diet (reduce caloric intake, become a vegetarian etc)

    • May possibly move away from the area for a new job, sabbatical, retirement etc

    • Plan to attempt to become pregnant

    • Have limited availability for any reason including prolonged vacation or business travel

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 National Cancer Institute (NCI), 9000 Rockville Pike Bethesda Maryland United States 20892

    Sponsors and Collaborators

    • National Cancer Institute (NCI)

    Investigators

    • Principal Investigator: Michael B Cook, M.D., National Cancer Institute (NCI)

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    National Cancer Institute (NCI)
    ClinicalTrials.gov Identifier:
    NCT01437033
    Other Study ID Numbers:
    • 999911243
    • 11-C-N243
    First Posted:
    Sep 20, 2011
    Last Update Posted:
    Apr 5, 2018
    Last Verified:
    Sep 23, 2016
    Keywords provided by National Cancer Institute (NCI)

    Study Results

    No Results Posted as of Apr 5, 2018